Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07552415

Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

Led by Hospital for Special Surgery, New York · Updated on 2026-04-27

170

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

H

Hospital for Special Surgery, New York

Lead Sponsor

O

Orthopaedic Research and Education Foundation (OREF)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to evaluate if knee immobilization for 10 days following revision total knee arthroplasty (rTKA) improves knee joint range of motion at 3 months postoperatively compared to standard of care postoperative protocol. Participants will be assigned to one of two groups. One group will wear a knee brace that keeps the knee straight for 10 days after surgery and will not perform knee range of motion exercises during that time. The other group will not wear a brace and will follow the standard physical therapy program, including knee range of motion exercises, starting after surgery.

CONDITIONS

Official Title

Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing revision TKA for aseptic indications including aseptic loosening, polyethylene wear, instability, malalignment, periprosthetic fracture.
  • Patients undergoing revision TKA of one or both components.
Not Eligible

You will not qualify if you...

  • Patients who are undergoing revision TKA for stiffness.
  • Patients with occult infection not recognized prior to revision.
  • Patients with hinged TKA component reconstructions.
  • Patients undergoing revision for liner exchange.
  • History of VTE/PE.
  • Patients on pre-operative anticoagulation.
  • BMI 64 40.
  • Patients with preoperative opioid use equal to or exceeding 150 Morphine Milligram Equivalents (MMEs)/day within 90 days of revision TKA.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital for Special Surgery

New York, New York, United States, 10021

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here